In a patient with a grade III ankle sprain and sickle cell disease, which option is contraindicated?

In a patient with a grade III ankle sprain and sickle cell disease, which option is contraindicated?

• A. Icing the ankle
• B. Using NSAIDs
• C. Compression of the ankle
• D. Elevation of the foot

Answer: (A)

In the case of a patient with a grade III ankle sprain and sickle cell disease, icing the ankle is contraindicated primarily due to the risk of vaso-occlusive crises associated with the disease. Sickle cell disease is characterized by the abnormal shape of red blood cells which can lead to blockages in blood vessels, especially in response to cold temperatures. When ice is applied to the injured area, it can cause constriction of blood vessels, reducing blood flow. This reduction can trigger pain and potential complications in patients with sickle cell disease by inducing a vaso-occlusive crisis. In contrast, other treatments such as using NSAIDs, compression, and elevation may be beneficial for managing pain and swelling while providing support and improving circulation to the affected area, thereby promoting healing without significantly increasing the risk of complications associated with sickle cell disease.

In the case of a patient with a grade III ankle sprain and sickle cell disease, icing the ankle is contraindicated primarily due to the risk of vaso-occlusive crises associated with the disease. Sickle cell disease is characterized by the abnormal shape of red blood cells which can lead to blockages in blood vessels, especially in response to cold temperatures. When ice is applied to the injured area, it can cause constriction of blood vessels, reducing blood flow. This reduction can trigger pain and potential complications in patients with sickle cell disease by inducing a vaso-occlusive crisis.

In contrast, other treatments such as using NSAIDs, compression, and elevation may be beneficial for managing pain and swelling while providing support and improving circulation to the affected area, thereby promoting healing without significantly increasing the risk of complications associated with sickle cell disease.